Connection
Maurizio Zangari to Myeloablative Agonists
This is a "connection" page, showing publications Maurizio Zangari has written about Myeloablative Agonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.572 |
|
|
|
-
Talamo G, Rakszawski KL, Rybka WB, Dolloff NG, Malysz J, Berno T, Zangari M. Effect of time to infusion of autologous stem cells (24 vs. 48?h) after high-dose melphalan in patients with multiple myeloma. Eur J Haematol. 2012 Aug; 89(2):145-50.
Score: 0.398
-
Kim JH, Goulston C, Sanders S, Lampas M, Zangari M, Tricot G, Hanson KE. Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation. Biol Blood Marrow Transplant. 2012 Nov; 18(11):1753-8.
Score: 0.100
-
Pineda-Roman M, Barlogie B, Anaissie E, Zangari M, Bolejack V, van Rhee F, Tricot G, Crowley J. High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients. Cancer. 2008 Apr 15; 112(8):1754-64.
Score: 0.075